|
|
|
Volumn 5, Issue 1, 2004, Pages 90-94
|
|
DP-b99 D-Pharm
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHELATING AGENT;
ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID;
ETHYLENEGLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID BIS(2 OCTYLOXYETHYL) ESTER;
FIBRINOLYTIC AGENT;
NEUROPROTECTIVE AGENT;
TISSUE PLASMINOGEN ACTIVATOR;
UNCLASSIFIED DRUG;
ANTICONVULSANT ACTIVITY;
ARTICLE;
BRAIN INJURY;
BRAIN ISCHEMIA;
CALCIUM METABOLISM;
CARDIOVASCULAR SYMPTOM;
CENTRAL NERVOUS SYSTEM DISEASE;
CLINICAL TRIAL;
CORONARY ARTERY BYPASS GRAFT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SCREENING;
DRUG SYNTHESIS;
DRUG TOLERABILITY;
DRUG TOXICITY;
ECG ABNORMALITY;
EPILEPSY;
HEAD INJURY;
HEADACHE;
HUMAN;
INJECTION SITE REACTION;
NAUSEA;
NERVE CELL NECROSIS;
NERVE INJURY;
NEUROPROTECTION;
NONHUMAN;
RAT;
SIDE EFFECT;
STROKE;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
BRAIN ISCHEMIA;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
CORONARY ARTERY BYPASS;
CRANIOCEREBRAL TRAUMA;
EGTAZIC ACID;
HUMANS;
NERVOUS SYSTEM DISEASES;
NEUROPROTECTIVE AGENTS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 2342434192
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
